![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cell‐Active, Reversible, and Irreversible Covalent Inhibitors That Selectively Target the Catalytic Lysine of BCR‐ABL Kinase
Peng Chen, Jie Sun, Chengjun Zhu, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 26
Open Access | Times Cited: 15
Peng Chen, Jie Sun, Chengjun Zhu, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 26
Open Access | Times Cited: 15
Showing 15 citing articles:
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 47
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 47
Applications of covalent chemistry in targeted protein degradation
Dong Lu, Xin Yu, Hanfeng Lin, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 22, pp. 9243-9261
Open Access | Times Cited: 29
Dong Lu, Xin Yu, Hanfeng Lin, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 22, pp. 9243-9261
Open Access | Times Cited: 29
How many kinases are druggable? A review of our current understanding
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 18
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 18
Technologies for Direct Detection of Covalent Protein–Drug Adducts
Elma Mons, Robbert Q. Kim, Monique P. C. Mulder
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 547-547
Open Access | Times Cited: 14
Elma Mons, Robbert Q. Kim, Monique P. C. Mulder
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 547-547
Open Access | Times Cited: 14
Chemoselective Reagents for the Traceless Bioreversible Modification of Native Proteins
Yana Petri, Forrest G. FitzGerald, Ronald T. Raines
Bioconjugate Chemistry (2024) Vol. 35, Iss. 9, pp. 1300-1308
Open Access | Times Cited: 1
Yana Petri, Forrest G. FitzGerald, Ronald T. Raines
Bioconjugate Chemistry (2024) Vol. 35, Iss. 9, pp. 1300-1308
Open Access | Times Cited: 1
A Tight Contact: The Expanding Application of Salicylaldehydes in Lysine‐Targeting Covalent Drugs
Mattia Mason, Laura Belvisi, Luca Pignataro, et al.
ChemBioChem (2023) Vol. 25, Iss. 7
Open Access | Times Cited: 4
Mattia Mason, Laura Belvisi, Luca Pignataro, et al.
ChemBioChem (2023) Vol. 25, Iss. 7
Open Access | Times Cited: 4
RGD Cyclopeptide Equipped with a Lysine‐Engaging Salicylaldehyde Showing Enhanced Integrin Affinity and Cell Detachment Potency
Giovanni Sacco, Daniela Arosio, Mayra Paolillo, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 19
Open Access | Times Cited: 3
Giovanni Sacco, Daniela Arosio, Mayra Paolillo, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 19
Open Access | Times Cited: 3
Structural elements that enable specificity for mutant EGFR kinase domains with next-generation small-molecule inhibitors
Tahereh Damghani, Florian Wittlinger, Tyler S. Beyett, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2023), pp. 171-198
Open Access | Times Cited: 3
Tahereh Damghani, Florian Wittlinger, Tyler S. Beyett, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2023), pp. 171-198
Open Access | Times Cited: 3
Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein–Protein Interaction Inhibitors
Karol R. Francisco, Jessica Bruystens, Carmine Varricchio, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 11, pp. 1651-1658
Open Access | Times Cited: 3
Karol R. Francisco, Jessica Bruystens, Carmine Varricchio, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 11, pp. 1651-1658
Open Access | Times Cited: 3
Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets
Jesang Lee, Seung Bum Park
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1478-1478
Open Access | Times Cited: 5
Jesang Lee, Seung Bum Park
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1478-1478
Open Access | Times Cited: 5
Synthesis of Noncoded Amino Acids Bearing a Salicylaldehyde Tag for the Design of Reversible‐Covalent Peptides
Mattia Mason, Beatrice Nava, Laura Belvisi, et al.
European Journal of Organic Chemistry (2024) Vol. 27, Iss. 22
Open Access
Mattia Mason, Beatrice Nava, Laura Belvisi, et al.
European Journal of Organic Chemistry (2024) Vol. 27, Iss. 22
Open Access
Reversible Conjugation of Polypeptides and Proteins Utilizing a [3.3.1] Scaffold under Mild Conditions
Ryan J. Bartlett, Kelly D. Crisostomo, Qiang Zhang
Organic Letters (2024) Vol. 26, Iss. 30, pp. 6428-6432
Open Access
Ryan J. Bartlett, Kelly D. Crisostomo, Qiang Zhang
Organic Letters (2024) Vol. 26, Iss. 30, pp. 6428-6432
Open Access
An Innovative Approach to Address Neurodegenerative Diseases through Kinase-Targeted Therapies: Potential for Designing Covalent Inhibitors
Swapnil P. Bhujbal, Jung‐Mi Hah
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1295-1295
Open Access | Times Cited: 1
Swapnil P. Bhujbal, Jung‐Mi Hah
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1295-1295
Open Access | Times Cited: 1
Catalyst-Free Late-Stage Functionalization to Assemble α-acyloxyenamide Electrophiles for Selectively Profiling Conserved Lysine Residues
Yuanyuan Zhao, Duan Kang, Youlong Fan, et al.
(2023)
Open Access | Times Cited: 1
Yuanyuan Zhao, Duan Kang, Youlong Fan, et al.
(2023)
Open Access | Times Cited: 1
Structural elements that enable specificity for mutant EGFR kinase domains with next-generation small-molecule inhibitors.
Tahereh Damghani, Florian Wittlinger, Tyler S. Beyett, et al.
(2023)
Open Access
Tahereh Damghani, Florian Wittlinger, Tyler S. Beyett, et al.
(2023)
Open Access